Jiangsu Chia Tai Tianqing Pharmaceutical
Mar 10, 2020
Soft Tissue Sarcoma Treatment Market: Present treatment approaches and Unmet Needs
Soft tissue sarcoma- a rare tumor – accounting for less than 1% of all cancers – has the major unmet need in the form of limited treatment options for patients. Cytotoxic chemotherapy has been the mainstay of therapy for decades. Active drugs such as doxorubicin, ifosfamide, gemcitabine, taxanes, and several othe...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
